4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001725663-26-000002
Chief Financial Officer sold 7,988 shares at $12.25 ($97,892)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WENTWORTH KORY JAMES Chief Financial Officer | 2026-03-04 | Sale 10b5-1 | −7,988 | $12.25 | $97,892 | 137,987 | D |
| Open-market sales · 7,988 sh · avg $12.25 · $97,892 | |||||||
Loading xslF345X05/wk-form4_1772833002.xml…